These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2458746)

  • 21. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies.
    Lutton DA; Patrick S; Crockard AD; Stewart LD; Larkin MJ; Dermott E; McNeill TA
    J Med Microbiol; 1991 Oct; 35(4):229-37. PubMed ID: 1719202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
    Poxton IR; Brown R
    J Gen Microbiol; 1986 Sep; 132(9):2475-81. PubMed ID: 2432160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteroides fragilis strains express multiple capsular polysaccharides.
    Pantosti A; Tzianabos AO; Reinap BG; Onderdonk AB; Kasper DL
    J Clin Microbiol; 1993 Jul; 31(7):1850-5. PubMed ID: 8349763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.
    Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W
    J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa.
    Lam JS; Handelsman MY; Chivers TR; MacDonald LA
    J Bacteriol; 1992 Apr; 174(7):2178-84. PubMed ID: 1372599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen.
    Pincus SH; Smith MJ; Jennings HJ; Burritt JB; Glee PM
    J Immunol; 1998 Jan; 160(1):293-8. PubMed ID: 9551983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody to streptococcal group B carbohydrate: applications in latex agglutination and immunoprecipitin assays.
    Ruch FE; Smith L
    J Clin Microbiol; 1982 Jul; 16(1):145-52. PubMed ID: 6809789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae.
    Maeland JA; Afset JE; Lyng RV; Radtke A
    Clin Vaccine Immunol; 2015 Feb; 22(2):153-9. PubMed ID: 25540270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus.
    Ricci ML; von Hunolstein C; Gomez MJ; Parisi L; Tissi L; Orefici G
    J Med Microbiol; 1996 Jun; 44(6):475-81. PubMed ID: 8636965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the cross-reacting antigen among Actinobacillus pleuropneumoniae strains of serotype 1, 9 and 11 by use of monoclonal antibodies.
    Nakai T; Kawahara K; Danbara H; Kume K
    J Vet Med Sci; 1992 Aug; 54(4):707-10. PubMed ID: 1382625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The isolation and immunochemical characterisation of a cell-wall carbohydrate and a membrane lipocarbohydrate antigen of group B streptococcus, type II.
    Cumming CG; Hay AJ; Ross PW; Poxton IR
    J Med Microbiol; 1983 Feb; 16(1):53-60. PubMed ID: 6337263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 5.
    Nakai T; Kawahara K; Horiguchi Y; Danbara H; Kume K
    Am J Vet Res; 1992 Sep; 53(9):1519-23. PubMed ID: 1384404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the alpha antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody.
    Bevanger L; Iversen OJ; Naess AI
    APMIS; 1992 Jan; 100(1):57-62. PubMed ID: 1536721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology of group B Streptococcus type II antibody specificity.
    Gray BM; Pritchard DG; Springfield JD; Benak RJ; Dillon HC
    Epidemiol Infect; 1988 Oct; 101(2):347-54. PubMed ID: 3053221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence.
    Weintraub A; Lindberg AA; Kasper DL
    J Infect Dis; 1983 Apr; 147(4):780. PubMed ID: 6341482
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three different methods in monoclonal antibody-based detection of Streptococcus agalactiae protein serotype markers.
    Moyo SR; Maeland JA; Bevanger L
    APMIS; 1999 Mar; 107(3):263-9. PubMed ID: 10223298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.